Comparative Pharmacology
Head-to-head clinical analysis: ISOLYTE P IN DEXTROSE 5 IN PLASTIC CONTAINER versus PLASMA LYTE 56 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: ISOLYTE P IN DEXTROSE 5 IN PLASTIC CONTAINER versus PLASMA LYTE 56 IN PLASTIC CONTAINER.
ISOLYTE P IN DEXTROSE 5% IN PLASTIC CONTAINER vs PLASMA-LYTE 56 IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
ISOLYTE P in Dextrose 5% provides electrolytes (sodium, potassium, magnesium, chloride, acetate, phosphate) and dextrose to maintain fluid and electrolyte balance, restore intravascular volume, and supply calories. Dextrose is metabolized to carbon dioxide and water, providing energy. Acetate acts as an alkalinizing agent, metabolized to bicarbonate in the liver.
PLASMA-LYTE 56 is an isotonic crystalloid solution that provides electrolytes and water to maintain or restore intravascular volume and electrolyte balance. It expands extracellular fluid volume and improves circulation by increasing plasma volume. The solution's electrolyte composition mimics plasma, helping to correct electrolyte deficits and acid-base disturbances.
Intravenous infusion; dose determined by fluid, electrolyte, and caloric requirements. Typical adult rate: 100-200 mL/hr; maximum infusion rate 10 mL/min.
Intravenous infusion; dose depends on fluid and electrolyte needs; typical adult rate: 100-200 mL/hour.
None Documented
None Documented
Not applicable as a combination product. Dextrose: 1-2 hours (metabolic clearance). Electrolytes: distribution half-life ~15-30 minutes, elimination depends on renal function; in normal renal function, complete clearance within 2-4 hours.
Not applicable as a fixed value; infused electrolytes distribute and are eliminated according to individual ion kinetics (e.g., sodium t½ ~30 min, chloride t½ ~1–2 h) with rapid redistribution.
Renal: 100% (electrolytes and dextrose metabolites, primarily water and CO2). No biliary or fecal elimination of significant amount.
Primarily renal; >90% of infused electrolytes are excreted unchanged in urine; fecal elimination negligible (<5%).
Category C
Category C
Intravenous Electrolyte Solution
Intravenous Electrolyte Solution